Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)
- Conditions
- Multiple Myeloma
- Registration Number
- NCT05161598
- Lead Sponsor
- Janssen Research & Development, LLC
- Brief Summary
Teclistamab pre-approval access in relapsed or refractory multiple myeloma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NO_LONGER_AVAILABLE
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method